The chemical class termed 4930579G22Rik Inhibitors encompasses a diverse range of compounds, each characterized by distinct molecular structures and mechanisms of action. This class is defined not by its direct interaction with the protein 4930579G22Rik, but rather through its influence on cellular pathways and processes that are presumably modulated by this protein. The inhibitors in this class demonstrate a broad spectrum of action, targeting key enzymes and receptors that play critical roles in cellular signaling, growth, metabolism, and survival.
A primary characteristic of these inhibitors is their ability to modulate kinase activity. Kinases are enzymes that catalyze the transfer of phosphate groups, a crucial process in cell signaling. For instance, Staurosporine and its derivatives are known for their broad-spectrum inhibition of protein kinases, thereby influencing various signaling pathways. Similarly, compounds like LY294002 and Wortmannin target the PI3K pathway, pivotal in cell growth and survival. Inhibition of this pathway can alter downstream effects, impacting a range of cellular functions.
Another significant aspect of these inhibitors is their role in modulating the MAPK pathway, critical in cell proliferation and differentiation. Compounds like U0126, PD98059, and SB203580 specifically target key enzymes within this pathway, leading to altered cellular responses. This modulation is crucial as it impacts crucial aspects of cell function, including growth, differentiation, and response to external stimuli.
Furthermore, some members of this class target proteasomes and tyrosine kinases. Proteasome inhibitors like Bortezomib disrupt the protein degradation mechanism, impacting cell cycle and survival. Tyrosine kinase inhibitors such as Sorafenib and Gefitinib target receptors involved in cell signaling and proliferation, thus affecting growth and survival pathways.
In summary, the 4930579G22Rik Inhibitors class represents a collection of chemical compounds that, through their distinct molecular actions, can influence various cellular processes and pathways. These inhibitors act on key enzymes and receptors, thereby modulating signaling pathways, cellular metabolism, growth, and survival. Their diverse mechanisms highlight the complexity and interconnectedness of cellular functions and underscore the significance of such compounds in exploring cellular biology.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A potent protein kinase inhibitor, can inhibit protein phosphorylation. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibits mTOR pathway, affecting protein synthesis and cell proliferation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Inhibits PI3K, influencing various signaling pathways related to growth. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
Inhibits MEK1/2, affecting MAPK/ERK pathway involved in cell signaling. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Inhibits p38 MAPK, affecting inflammatory response and cell differentiation. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Inhibits MEK, which modulates the MAPK/ERK signaling pathway. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Inhibits PI3K, affecting cellular processes like growth and metabolism. | ||||||
Triciribine | 35943-35-2 | sc-200661 sc-200661A | 1 mg 5 mg | $104.00 $141.00 | 14 | |
Inhibits Akt, involved in cell survival and growth pathways. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibits JNK, affecting cell differentiation and apoptosis. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Inhibits proteasome, affecting protein degradation pathways. | ||||||